Laure-Hélène Mercier

Laure-Hélène Mercier, EVP, Finance and Corporate Strategy, joined Innate Pharma in 2007 and was appointed Chief Financial Officer in December 2016. Prior to her current position, Ms. Mercier served as Executive Vice President, Finance beginning in October 2016 and was previously our Director of Investor Relations. Prior to joining, Ms. Mercier held positions as an equity analyst at Oddo Securities and Natexis Bleichroeder. She has a MSc in Neurosciences from Université Aix-Marseille and a MBA from ESSEC Business School.